Ameritas Investment Partners Inc. Has $2.07 Million Position in STERIS PLC (STE)
Ameritas Investment Partners Inc. boosted its position in shares of STERIS PLC (NYSE:STE) by 1.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,416 shares of the medical equipment provider’s stock after acquiring an additional 379 shares during the period. Ameritas Investment Partners Inc.’s holdings in STERIS PLC were worth $2,071,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently bought and sold shares of the stock. Janus Capital Management LLC lifted its position in STERIS PLC by 0.4% during the first quarter. Janus Capital Management LLC now owns 8,669,694 shares of the medical equipment provider’s stock valued at $602,192,000 after acquiring an additional 33,758 shares during the last quarter. Janus Henderson Group PLC increased its stake in STERIS PLC by 1,972.4% during the 2nd quarter. Janus Henderson Group PLC now owns 7,679,507 shares of the medical equipment provider’s stock valued at $625,880,000 after purchasing an additional 7,308,950 shares in the last quarter. BlackRock Inc. increased its stake in STERIS PLC by 33.4% during the 2nd quarter. BlackRock Inc. now owns 7,032,984 shares of the medical equipment provider’s stock valued at $573,188,000 after purchasing an additional 1,760,879 shares in the last quarter. Vanguard Group Inc. increased its stake in STERIS PLC by 1.6% during the 2nd quarter. Vanguard Group Inc. now owns 6,879,760 shares of the medical equipment provider’s stock valued at $560,700,000 after purchasing an additional 107,644 shares in the last quarter. Finally, FMR LLC increased its stake in STERIS PLC by 33.1% during the 2nd quarter. FMR LLC now owns 3,454,533 shares of the medical equipment provider’s stock valued at $281,544,000 after purchasing an additional 859,228 shares in the last quarter. 93.33% of the stock is owned by institutional investors.
Shares of STERIS PLC (NYSE:STE) traded down 0.02% on Friday, reaching $90.58. 120,448 shares of the company’s stock were exchanged. The firm has a 50 day moving average of $87.61 and a 200 day moving average of $80.59. STERIS PLC has a one year low of $63.80 and a one year high of $91.18. The firm has a market capitalization of $7.72 billion, a P/E ratio of 64.79 and a beta of 1.29.
STERIS PLC (NYSE:STE) last issued its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.05. STERIS PLC had a net margin of 4.63% and a return on equity of 11.39%. The business had revenue of $608.00 million during the quarter, compared to the consensus estimate of $597.66 million. During the same quarter in the previous year, the firm earned $0.79 EPS. The company’s revenue was down 4.8% compared to the same quarter last year. On average, equities research analysts predict that STERIS PLC will post $4.06 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Thursday, September 28th. Investors of record on Tuesday, August 29th were given a $0.31 dividend. This is an increase from STERIS PLC’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend was Friday, August 25th. This represents a $1.24 annualized dividend and a yield of 1.37%. STERIS PLC’s dividend payout ratio is 88.57%.
STE has been the topic of a number of recent analyst reports. Zacks Investment Research lowered shares of STERIS PLC from a “buy” rating to a “hold” rating in a research note on Tuesday, August 22nd. Raymond James Financial, Inc. upped their price target on shares of STERIS PLC from $90.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, August 9th. Finally, BidaskClub lowered shares of STERIS PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $89.00.
In related news, VP Karen L. Burton sold 3,270 shares of the company’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $85.70, for a total value of $280,239.00. Following the completion of the sale, the vice president now owns 11,807 shares in the company, valued at approximately $1,011,859.90. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the company’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $85.69, for a total transaction of $856,900.00. Following the completion of the sale, the chief executive officer now owns 83,270 shares of the company’s stock, valued at approximately $7,135,406.30. The disclosure for this sale can be found here. In the last quarter, insiders sold 194,086 shares of company stock valued at $16,953,621. 2.55% of the stock is owned by insiders.
About STERIS PLC
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Stock Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related stocks with our FREE daily email newsletter.